These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 34669933)

  • 21. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    States V; O'Brien S; Rai JP; Roberts HL; Paas M; Feagins K; Pierce EJ; Baumgartner RN; Galandiuk S
    Dig Dis Sci; 2020 Sep; 65(9):2675-2685. PubMed ID: 31925675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.
    Adam H; Alqassas M; Saadah OI; Mosli M
    J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucocutaneous manifestations in inflammatory bowel disease.
    Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
    Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
    Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.
    Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.
    Jansen FM; Vavricka SR; den Broeder AA; de Jong EM; Hoentjen F; van Dop WA
    United European Gastroenterol J; 2020 Nov; 8(9):1031-1044. PubMed ID: 32921269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
    Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
    Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Rogler G; Singh A; Kavanaugh A; Rubin DT
    Gastroenterology; 2021 Oct; 161(4):1118-1132. PubMed ID: 34358489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fleisher M; Marsal J; Lee SD; Frado LE; Parian A; Korelitz BI; Feagan BG
    Dig Dis Sci; 2018 Apr; 63(4):825-833. PubMed ID: 29484571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review.
    Guillo L; D'Amico F; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2021 Jul; 15(7):1236-1243. PubMed ID: 33367674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
    Yang BR; Choi NK; Kim MS; Chun J; Joo SH; Kim H; Lee J
    PLoS One; 2018; 13(7):e0200363. PubMed ID: 29990326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study.
    Park SK; Wong Z; Park SH; Vu KV; Bang KB; Piyachaturawat P; Myint T; Hilmi I; Park DI
    Dig Liver Dis; 2021 Feb; 53(2):196-201. PubMed ID: 32736897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between erythema nodosum and pyoderma gangrenosum and pediatric inflammatory bowel disease.
    Yousif ML; Ritchey A; Mirea L; Patel AS; Price H; O'Haver J; Rudo-Stern J; Montoya L; Gonzalez-Llanos L; Smith J; Zeblisky K; Pasternak B
    J Pediatr Gastroenterol Nutr; 2024 Nov; 79(5):1009-1016. PubMed ID: 39248246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.